LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+49.6%
5Y CAGR+44.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+49.6%/yr
Annual compound
5Y CAGR
+44.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $85.28M | +45.6% |
| 2024 | $58.55M | -19.2% |
| 2023 | $72.43M | +184.2% |
| 2022 | $25.48M | -57.3% |
| 2021 | $59.71M | +346.3% |
| 2020 | $13.38M | +46034.5% |
| 2019 | $29000.00 | - |